Pricing & Access Solutions in APAC and Emerging Markets for the Pharma and MedTech sectors
Achieving your desired business impact for a drug or device in Asia Pacific, Latin America and other emerging markets requires an innovative approach to market access as well as effective implementation. We can help with both devising the right access and commercial strategy and supporting local teams in their execution, ensuring that your access-related goals are met.
Whether your challenge is how to maximise funding and accelerate timelines in reimbursed settings or maximising self-pay opportunities in out-of-pocket settings, we have the experience and local market network to provide you with the insights you need to make better informed decisions.
We're hiring - get in touch to find out more
We’re looking for candidates both at entry level (analyst) and at senior consultant, based either in the UK or in Asia (we’re flexible on location).
Email us at firstname.lastname@example.org to find out more
Pharmaceutical Pricing Research In Emerging Markets: It’s Not Just About The Numbers
A comprehensive out-of-pocket market access strategy is one of the critical cornerstones of launch into emerging markets.
Given the time lag in emerging market governmental agencies reimbursing innovative drugs and devices, out-of-pocket segments constitute an important business source in the first years after launch.
Read our full article here: https://bit.ly/2nSl1zd
Pricing & Reimbursement of Specialty Drugs in Asian Markets
At Ispor Singapore 2016 we presented a poster on the P&R status of specialty medicines across key Asian markets.
You can see the abstract here: https://bit.ly/2N5uxdj
If you’d like to discuss ways of maximising the access opportunities for your specialty brand, then drop us a line at email@example.com